Bluejay Diagnostics (BJDX) EPS (Weighted Average and Diluted) (2022 - 2023)
Historic EPS (Weighted Average and Diluted) for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to -$22.71.
- Bluejay Diagnostics' EPS (Weighted Average and Diluted) fell 105160.59% to -$22.71 in Q2 2023 from the same period last year, while for Sep 2023 it was -$58.29, marking a year-over-year decrease of 199014.2%. This contributed to the annual value of -$114.19 for FY2024, which is 9685.56% up from last year.
- Latest data reveals that Bluejay Diagnostics reported EPS (Weighted Average and Diluted) of -$22.71 as of Q2 2023, which was down 105160.59% from -$2.63 recorded in Q1 2023.
- In the past 5 years, Bluejay Diagnostics' EPS (Weighted Average and Diluted) registered a high of -$0.1 during Q1 2022, and its lowest value of -$22.71 during Q2 2023.